ATIP Report Abstracts 2001: Part 5
Posted with permission from ATIP
2001 ATIP Report Abstracts: Part 5
This report contains short abstracts, a few sentences, for each of the ATIP year 2001 Reports. A typical ATIP Report is in two parts, one public portion, and one subscriber portion, although this report is totally public. In 2001, ATIP produced 58 reports (including this one) on technology developments in and around Asia. The following is the titles of the 41st through 50th reports (see the rest at the URL above or in this series on the GLOCOM Platform).
- ATIP01.041 : DNA-Chip Related Activities in Korea
- ATIP01.042 : Korean Microsystems Update
- ATIP01.043 : Next-Generation Wireless R&D Activities in Korea
- ATIP01.044 : Bioinformatics Research in Australia
- ATIP01.045 : Nanotech R&D in Europe (I)
- ATIP01.046 : Nanotech R&D in Europe (II)
- ATIP01.047 : TMR Research in Japan
- ATIP01.048 : Biotech in China
- ATIP01.049 : Microarray Expression Profiling for Drug Discovery
- ATIP01.050 : Overview on Nano Science and Technology in China
2. ABSTRACTS OF YEAR 2001 ATIP TECHNOLOGY REPORTS
2001 ATIP Technology Reports are numbered sequentially, atip01.001, atip01.002, etc.
Date: 7 Sep 2001
ATIP01.041 : DNA-Chip Related Activities in Korea
ABSTRACT: The number of startup companies and research institutes engaged in DNA-chip related activities has been increasing rapidly over the past two years in Korea. Still, the number of companies with serious R&D efforts remains limited and, at an estimated 2 billion Korean won (US$1.5 million) during 2000, the Korean market for microarray devices remains negligible. Despite strong growth forecasts and some initial success with diagnostic applications of microarrays, the future of DNA microarray technology in Korea remains uncertain.
Date: 11 Sep 2001
ATIP01.042 : Korean Microsystems Update
ABSTRACT: This report provides a detailed update of Korean Microsystems (MEMS) R&D activities. Recent years have seen the establishment of more than 20 start-ups that specialize in IT and biomedical areas. We provide a list of start-ups and their business strategies. In addition, we describe ongoing research at large firms and government R&D initiatives. We also provide a list of papers presented at the K-MEMS 2001 to help the reader grasp the current trends in MEMS research in Korea.
Date: 14 Sep 2001
ATIP01.043 : Next-Generation Wireless R&D Activities in Korea
ABSTRACT: Following the implementation of CDMA technology for commercial use in Korea in 1996, the country's mobile communication market has grown rapidly. With over 27 million subscribers generating a total annual service revenue of around US$9 billion, Korea's mobile communications market is the 7 th largest among OECD member countries. But, despite this considerable market size, the transition towards 3G systems -- which is scheduled for launch in May 2002 -- is confronted with serious obstacles. High royalty fees for existing services – the result of a pervious overemphasis on commercialization & application and a lack of basic R&D -- have been a main motivation to accelerate R&D on future generation wireless systems, and especially WCDMA, in government and industry. This report provides a broad overview to R&D efforts on 3G and 4G mobile telephony funded by the Korean government and key industry players. An accompanying database provides a list of labs active I R&D for future mobile communication systems.
Date: 18 Sep 2001
ATIP01.044 : Bioinformatics Research in Australia
ABSTRACT: Australia has an appropriate natural environment along with a well developed infrastructure for biomedical research and industrial biotechnology. Research and industrialization of genomics and bioinformatics ought to be a natural outgrowth if sufficient support and encouragement is provided by government. However, future support for genomics and bioinformatics research remains uncertain. This report provides an overview of bioinformatics and computational biology related activities in Australia, including both university and industrial efforts.
Date: 25 Sep 2001
ATIP01.045 : Nanotech R&D in Europe (I)
ABSTRACT: This report (the first of two parts) presents significant European nanotechnology (nanotech) programs and research at institutes and industry in the United Kingdom (UK), Germany, France, the Netherlands and Belgium. The report outlines activities and developments, European and national programs and projected future developments in nanotechnology. Part II of this report (ATIP01.046) highlights Sweden, Finland, Denmark, and Switzerland.
Date: 28 Sep 2001
ATIP01.046 : Nanotech R&D in Europe (II)
ABSTRACT: This report presents significant European nanotechnology (nanotech) R&D at institutes and industry in Sweden, Finland, Denmark, and Switzerland. It outlines activities and programs in the individual countries, as well as projected future developments in nanotechnology. This is Part II a two-part report (for Part I, see ATIP01.045).
Date: 2 Oct 2001
ATIP01.047 : TMR Research in Japan
ABSTRACT: The new field of magnetronics combines standard microelectronics with spin-dependent effects that arise from the interaction between electrons and a magnetic field. Fundamental and applied research are being actively pursued based on tunneling magnetoresistance (TMR), with significant potential applications in magnetic random access memory and magnetic read head technology. This report describes the research activities in Japan, and especially that focused on magnetic read-head technology.
Date: 5 Oct 2001
ATIP01.048 : Biotech in China
ABSTRACT: This short report provides a snapshot of the major biotech research facilities in China, as well as a few examples of startup companies. R&D is almost exclusively financed by government sources.
Date: 10 Oct 2001
ATIP01.049 : Microarray Expression Profiling for Drug Discovery
ABSTRACT: In April 2000, as part of Japan's Millennium Project, the Ministry of International Trade and Industry (MITI, now METI), provided 1.9 billion Yen to the Japan Biological Informatics Consortium (JBIC) a one-year program under the name of Protein Function Analysis. One of the projects, Construction of R&D of Mass-gene Expression Profile Database for Human Genome Exploration was recently completed with experimental data resulting from the cooperative work of six Japanese companies and three academic groups. In addition a multi-functional pharmaceutical bioactive substances database, including detailed information for substances used in expression data, was constructed for drug discovery. This report gives details of the mass-microarray expression profile database as well as the contents of associated pharmaceutical bioactive substance database.
Date: 24 Oct 2001
ATIP01.050 : Overview on Nano Science and Technology in China
ABSTRACT: This report outlines the latest National Nanotechnology Initiative in China. We summarize the current state of art nano science and technology development in China. The characteristics of Chinese Nano science and technology development are also discussed.
(to be continued)
ATIP offers a full range of information services including reports, assessments, briefings, visits, sample procurements, workshops, cultural/business sensitivity training, and liaison activities, all performed by our on-the- ground multilingual experts.
Asian Technology Information Program
Harks Roppongi Building 1F 6-15-21 Roppongi, Minato-ku
Tokyo 106, JAPAN
Tel: +81 3 5411-6670
Fax: +81 3 5411-6671
Asian Technology Information Program
P.O. Box 9678 Albuquerque, New Mexico 87119
Tel: (505) 842-9020
Fax: (505) 766-5166
For further information:
Website: http://www.atip.or.jp OR http://www.atip.org